(Q36455153)

English

Randomized, double-blind, placebo-controlled trial of sulindac in individuals at risk for melanoma: evaluation of potential chemopreventive activity

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Randomized, double-blind, placebo-controlled trial of sulindac in individuals at risk for melanoma: evaluation of potential chemopreventive activity (English)

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

0 references

placebo-controlled trial

1 reference

based on heuristic

inferred from title

Janine G Einspahr

3

object named as

Janine G Einspahr

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

David S. Alberts

9

object named as

David S Alberts

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

author name string

Clara Curiel-Lewandrowski

1

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Susan M Swetter

2

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Chiu-Hsieh Hsu

4

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Ray Nagle

5

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Paul Sagerman

6

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Joseph Tangrea

7

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Howard Parnes

8

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Hsiao-Hui Chow

10

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

language of work or name

0 references

publication date

17 May 2012

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

118

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

23

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

5848-5856

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Sulindac and sulindac metabolites in nipple aspirate fluid and effect on drug targets in a phase I trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3517927

30 September 2017

Expression of vascular endothelial growth factor in early cutaneous melanocytic lesion progression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3517927

30 September 2017

Dysplastic naevi with moderate to severe histological dysplasia: a risk factor for melanoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3517927

30 September 2017

Cytostatic and cytotoxic effects of cyclooxygenase inhibitors and their synergy with docosahexaenoic acid on the growth of human skin melanoma A-375 cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3517927

30 September 2017

Meta-analysis of risk factors for cutaneous melanoma: III. Family history, actinic damage and phenotypic factors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3517927

30 September 2017

Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3517927

30 September 2017

Inhibition of angiogenesis by non-steroidal anti-inflammatory drugs: from the bench to the bedside and back

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3517927

30 September 2017

Suppression of accelerated tumor growth in surgical wounds by celecoxib and indomethacin.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3517927

30 September 2017

Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3517927

30 September 2017

Meta-analysis of risk factors for cutaneous melanoma: I. Common and atypical naevi

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3517927

30 September 2017

Inhibition of angiogenesis by NSAIDs: molecular mechanisms and clinical implications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3517927

30 September 2017

Progression and NSAID-induced apoptosis in malignant melanomas are independent of cyclooxygenase II.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3517927

30 September 2017

Inverse association of non-steroidal anti-inflammatory drugs and malignant melanoma among women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3517927

30 September 2017

Clinical pharmacokinetics of sulindac. A dynamic old drug

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3517927

30 September 2017

Atypical mole syndrome: risk factor for cutaneous malignant melanoma and implications for management

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3517927

30 September 2017

Sulindac: therapeutic implications of the prodrug/pharmacophore equilibrium

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3517927

30 September 2017

Effect of vitamin E and indomethacin treatment on adenylate cyclase activity, PGE2 and cAMP levels in murine melanoma cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3517927

28 June 2018

Identification of the biologically active form of sulindac

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3517927

28 June 2018

Cyclooxygenase-2 inhibition improves macrophage function in melanoma and increases the antineoplastic activity of interferon gamma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27540

21 January 2018

Non-steroidal anti-inflammatory drugs and melanoma risk: large Dutch population-based case-control study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27540

21 January 2018

Photoprotective effects of sulindac against ultraviolet B-induced phototoxicity in the skin of SKH-1 hairless mice

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27540

21 January 2018

Inhibition of chemically induced skin carcinogenesis by sulindac is independent of peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta).

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27540

21 January 2018

Sensitivity, specificity, and diagnostic accuracy of three dermoscopic algorithmic methods in the diagnosis of doubtful melanocytic lesions: the importance of light brown structureless areas in differentiating atypical melanocytic nevi from thin mel

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27540

21 January 2018

A three-year randomized trial in patients with dysplastic naevi treated with oral beta-carotene

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27540

21 January 2018

Immunohistochemical expression of vascular endothelial growth factor, matrix metalloproteinase 2, and matrix metalloproteinase 9 in cutaneous melanocytic lesions.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27540

21 January 2018

Immunohistochemical expression of vascular endothelial growth factor (VEGF) and C-KIT in cutaneous melanocytic lesions

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27540

21 January 2018

Vascular endothelial growth factor-C expression correlates with lymph node localization of human melanoma metastases.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27540

21 January 2018

Correlation between clinical atypia and histologic dysplasia in acquired melanocytic nevi.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27540

21 January 2018

Treatment of dysplastic nevi with 5% imiquimod cream, a pilot study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3517927

21 September 2018

Alterations of gene expression in skin and lung of mice exposed to light and cigarette smoke.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3517927

21 September 2018

Augmented antitumor effect of recombinant human interleukin-1 alpha by indomethacin

1 reference

https://pubmed.ncbi.nlm.nih.gov/22605570

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of oral isotretinoin on dysplastic nevi

1 reference

https://pubmed.ncbi.nlm.nih.gov/22605570

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of topical tretinoin on dysplastic nevi. A preliminary trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/22605570

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of topical tretinoin on dysplastic nevi

1 reference

https://pubmed.ncbi.nlm.nih.gov/22605570

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of topical tretinoin under occlusion on atypical naevi

1 reference

https://pubmed.ncbi.nlm.nih.gov/22605570

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

VEGF and VEGFR-2 immunohistochemistry in human melanocytic naevi and cutaneous melanomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/22605570

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of cyclooxygenase inhibitors and risk of melanoma in high-risk patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/22605570

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Distribution and colocalization of markers for proliferation, invasion, motility and neoangiogenesis in benign melanocytic naevi and malignant melanomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/22605570

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of endothelial nitric oxide synthase and vascular endothelial growth factor in human malignant melanoma and their relation to angiogenesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22605570

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Localization of vascular endothelial growth factor-D in malignant melanoma suggests a role in tumour angiogenesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22605570

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term use of nonsteroidal anti-inflammatory drugs decreases the risk of cutaneous melanoma: results of a United States case-control study

1 reference

https://pubmed.ncbi.nlm.nih.gov/22605570

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of topical tretinoin in melanoma and dysplastic nevi

1 reference

https://pubmed.ncbi.nlm.nih.gov/22605570

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1002/CNCR.27540

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36455153&oldid=2076549140"